Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01184638
Other study ID # NJMU-2010-07022
Secondary ID NJFY7M12
Status Recruiting
Phase Phase 4
First received August 16, 2010
Last updated January 11, 2014
Start date August 2010
Est. completion date August 2020

Study information

Verified date January 2014
Source Nanjing Medical University
Contact FuZhou Wang, PhD MD
Phone 86 25 84460777
Email zfwang50@gmail.com
Is FDA regulated No
Health authority China: Ethics Committee
Study type Interventional

Clinical Trial Summary

Cognitive disorders in patients underwent general anesthesia are discussed for decades, but whether there were precise relationship between general anesthesia and dysgnosia is yet to be guaranteed. Although controversial data reported from experimental studies in animals, the investigators still proposed that general anesthetics could impair the normally organized system of the central nervous system, which finally displayed a dysfunction of cognition after general anesthesia in a short- or long-term period. Therefore, different types of general anesthetics such as inhalational anesthetics and intravenous anesthetics, the investigators hypothesized, had a long-term influence on patients' cognitive ability.


Recruitment information / eligibility

Status Recruiting
Enrollment 10000
Est. completion date August 2020
Est. primary completion date August 2020
Accepts healthy volunteers No
Gender Both
Age group 10 Years to 80 Years
Eligibility Inclusion Criteria:

- Patients with informed consents

- Without basal disorders of neurology and psychiatrics

Exclusion Criteria:

- With the history of cognitive disorders

- With chronic neurological disorders

- Cannot communicate with investigators

- Cannot stand general anesthesia

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment


Intervention

Drug:
Sevoflurane
1-8% sevoflurane for maintaining the whole period of general anesthesia
Propofol
1-4 mg/kg/h of propofol during the whole period of general anesthesia

Locations

Country Name City State
China Nanjing Maternity and Child Health Care Hospital Nanjing Jiangsu

Sponsors (1)

Lead Sponsor Collaborator
Nanjing Medical University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cognitive ability Cognitive ability will be assessed with digital lignature game, figure identificaiton, and recall memory The 10th year since postoperation Yes
Secondary Cognitive ability Cognitive ability will be assessed with digital lignature game, figure identificaiton, and recall memory One hour before operation Yes
Secondary Cognitive ability Cognitive ability will be assessed with digital lignature game, figure identificaiton, and recall memory Immediately after operation (0 day) Yes
Secondary Cognitive ability Cognitive ability will be assessed with digital lignature game, figure identificaiton, and recall memory One month after operation Yes
Secondary Cognitive ability Cognitive ability will be assessed with digital lignature game, figure identificaiton, and recall memory Six month after operation Yes
Secondary Cognitive ability Cognitive ability will be assessed with digital lignature game, figure identificaiton, and recall memory One year after operation Yes
Secondary Cognitive ability Cognitive ability will be assessed with digital lignature game, figure identificaiton, and recall memory Once a year from the 1st year after operation up to 9th year Yes
See also
  Status Clinical Trial Phase
Completed NCT02554253 - The Impact of Ketamine on Postoperative Cognitive Dysfunction, Delirium, and Renal Dysfunction Phase 2
Recruiting NCT02777060 - Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures N/A
Completed NCT02342041 - A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-G3031 in Healthy Subjects Phase 1
Recruiting NCT01659593 - Evaluation of the Efficiency of a Cognitive Remedial Program (PROCOG-SEP) Designed for Multiple Sclerosis Patients N/A
Completed NCT01561820 - Mild Cognitive Impairment, Buddy Supported Exercise/ My Buddy Study N/A
Completed NCT00743405 - Safety, Tolerability and Pharmacokinetics of GSK1034702 in Healthy Subjects Phase 1
Completed NCT05373394 - Evaluation of Cognitive and Motor Neurological Disorders in the Short and Long Term After Surgery for the Removal of a Diffuse Low-grade Glioma of the Supplementary Motor Area
Completed NCT04860414 - Prospective Monocentric Study of Taste in Patients With Minor or Major Cognitive Disorders Such as Alzheimer's, Through the Analysis of Gustatory Evoked Potentials. N/A
Completed NCT02324153 - Ramelteon in the Prevention of Post-operative Delirium Phase 2
Completed NCT00458094 - Peer Support for Increasing Physical Activity in People With Serious Mental Illnesses N/A
Completed NCT05486195 - A Single Ascending Oral Dose Study of SDI-118 in Healthy Male Subjects Including an Assessment of Receptor Occupancy and Food Effect Phase 1
Not yet recruiting NCT03866018 - Contribution of Physical Activity to Self-esteem and Motivation in Older Adults With Minor to Major Cognitive Disorders Such as Alzheimer's Disease or Related Disorders N/A
Recruiting NCT02876536 - Effect of Transcutaneous Electrical Nerve Stimulation on Cognition in Multiple Sclerosis Patients N/A
Completed NCT02321475 - EGb 761® (Tanakan®) Effectiveness in the Treatment of Patients of Middle Age and Younger With Psycho-emotional Symptoms, Added to Cognitive Disorders
Completed NCT01881646 - Postoperative Neuroinflammation and Cognitive Dysfunction After Abdominal Surgery Phase 4
Recruiting NCT05888961 - Single-center Prospective Longitudinal Study of Taste in Patients With Cognitive Disorders at Different Stages of Severity (Isolated Cognitive Complaint, Minor or Major Neurocognitive Alzheimer-type Disorders) by Analysis of Gustatory Evoked Potentials N/A
Completed NCT02575482 - A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-D4010 in Healthy Subjects Phase 1
Completed NCT01983384 - Anesthetic Depth and Postoperative Delirium Trial - 2 N/A
Completed NCT00937846 - Brain Uptake of GSK1034702: a Positron Emission Tomography (PET) Scan Study Phase 1
Completed NCT01772095 - ADVANCE Study: Alzheimer Disease eVAluation iN Clinical PracticE N/A